BCM
CNTB

BML Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

BML Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
573,287
+164,400
+40% +$399K 0.78% 14
2026
Q1 		$1.07M Hold
408,887
– – 0.69% 14
2025
Q4 		$1.15M Sell
408,887
-858,613
-68% -$1.83M 1% 13
2025
Q3 		$1.91M Sell
1,267,500
-554,058
-30% -$981K 1.75% 10
2025
Q2 		$1.79M Sell
1,821,558
-271,674
-13% -$217K 1.35% 15
2025
Q1 		$1.15M Hold
2,093,232
– – 0.93% 16
2024
Q4 		$2.89M Hold
2,093,232
– – 1.79% 13
2024
Q3 		$3.01M Buy
2,093,232
+49,984
+2% +$61K 1.77% 13
2024
Q2 		$3.11M Sell
2,043,248
-18,090
-0.9% -$29.7K 2.22% 11
2024
Q1 		$3.59M Sell
2,061,338
-100
-0% -$122 2.37% 11
2023
Q4 		$2.43M Buy
+2,061,438
New +$2.45M 1.84% 14

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BML Capital Management's CNTB Position: Q2 2026 in Review

BML Capital Management increased its Connect Biopharma Holdings (CNTB) stake by 40% in Q2 2026, buying an estimated $399K and bringing the position to 573,287 shares worth $1.36M. The position accounts for 0.78% of the portfolio, ranked #14.

BML Capital Management first reported a position in CNTB in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.59M in Q1 2024. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • BML Capital Management held 573,287 shares of Connect Biopharma Holdings worth $1.36M as of Q2 2026.
  • BML Capital Management bought 164,400 Connect Biopharma Holdings shares in Q2 2026, an estimated $399K.
  • Connect Biopharma Holdings made up 0.78% of BML Capital Management's portfolio in Q2 2026, its #14 holding.
  • BML Capital Management first reported a position in Connect Biopharma Holdings in Q4 2023 and has held it in 11 quarters since.
  • BML Capital Management's Connect Biopharma Holdings position peaked at $3.59M in Q1 2024.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on BML Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.